← All companies
NEOGENOMICS INC
NEO - CIK 0001077183
Market cap$1.49 B
Rank#2325
SEC filings1,246
The table below shows NEOGENOMICS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | $413.04M | $370.47M | $347.04M | $321.83M | $297.27M | $258.56M |
| Gross profit | $314.29M | $290.10M | $244.60M | $187.90M | $187.06M | $185.89M |
| R&D | $37.08M | $31.16M | $27.31M | $30.33M | $21.87M | $8.23M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.